Us Bancorp \De\ Guardant Health, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Guardant Health, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 33,022 shares of GH stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,022

Previous 24,676 33.82%

Holding current value

$1.13 Million

Previous $712,000 6.32%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$22.3 - $36.29 $186,115 - $302,876	8,346 Added 33.82%	33,022 $757,000
Q2 2024 Aug 06, 2024	SELL	$16.07 - $31.84 $141,753 - $280,860	-8,821 Reduced 26.33%	24,676 $712,000
Q1 2024 May 07, 2024	SELL	$17.13 - $26.91 $78,438 - $123,220	-4,579 Reduced 12.03%	33,497 $691,000
Q4 2023 Feb 09, 2024	BUY	$21.58 - $29.5 $557,454 - $762,044	25,832 Added 210.98%	38,076 $1.03 Million
Q3 2023 Nov 03, 2023	SELL	$25.8 - $39.97 $20,949 - $32,455	-812 Reduced 6.22%	12,244 $362,000
Q2 2023 Aug 09, 2023	BUY	$20.94 - $38.01 $48,141 - $87,384	2,299 Added 21.37%	13,056 $467,000
Q1 2023 May 09, 2023	BUY	$22.92 - $33.76 $18,060 - $26,602	788 Added 7.9%	10,757 $252,000
Q4 2022 Feb 13, 2023	SELL	$25.44 - $59.78 $134,297 - $315,578	-5,279 Reduced 34.62%	9,969 $271,000
Q3 2022 Oct 27, 2022	BUY	$43.66 - $61.0 $82,561 - $115,351	1,891 Added 14.16%	15,248 $821,000
Q2 2022 Aug 01, 2022	BUY	$28.82 - $77.35 $15,822 - $42,465	549 Added 4.29%	13,357 $538,000
Q1 2022 May 11, 2022	BUY	$48.25 - $100.49 $30,494 - $63,509	632 Added 5.19%	12,808 $849,000
Q4 2021 Feb 11, 2022	BUY	$88.71 - $120.43 $171,387 - $232,670	1,932 Added 18.86%	12,176 $1.22 Million
Q3 2021 Nov 10, 2021	BUY	$98.77 - $132.17 $344,608 - $461,141	3,489 Added 51.65%	10,244 $1.28 Million
Q2 2021 Aug 05, 2021	BUY	$109.77 - $165.68 $34,577 - $52,189	315 Added 4.89%	6,755 $839,000
Q1 2021 Apr 28, 2021	BUY	$127.04 - $179.1 $592,260 - $834,964	4,662 Added 262.2%	6,440 $982,000
Q4 2020 Feb 04, 2021	BUY	$99.96 - $135.93 $13,994 - $19,030	140 Added 8.55%	1,778 $230,000
Q3 2020 Nov 10, 2020	BUY	$80.32 - $111.8 $12,288 - $17,105	153 Added 10.3%	1,638 $183,000
Q2 2020 Aug 07, 2020	SELL	$60.49 - $97.5 $36,656 - $59,085	-606 Reduced 28.98%	1,485 $121,000
Q1 2020 May 13, 2020	BUY	$59.04 - $88.81 $70,552 - $106,127	1,195 Added 133.37%	2,091 $146,000
Q4 2019 Feb 04, 2020	BUY	$59.49 - $82.78 $59 - $82	1 Added 0.11%	896 $70,000
Q3 2019 Nov 08, 2019	BUY	$62.59 - $110.3 $52,888 - $93,203	845 Added 1690.0%	895 $57,000
Q2 2019 Aug 13, 2019	BUY	$63.94 - $91.11 $3,197 - $4,555	50 New	50 $4,000

Others Institutions Holding GH

# of Institutions

324

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.51B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account